CALABRESE, ANNA
CALABRESE, ANNA
SCIENZE MEDICHE
Adjuvant mitotane therapy is beneficial in non-metastatic adrenocortical carcinoma at high risk of recurrence.
2019-01-01 Calabrese A, Basile V, Puglisi S, Perotti P, Pia A, Saba L, Berchialla P, Porpiglia F, Veltri A, Volante M, Reimondo G, Berruti A, Terzolo M.
Effects of germline CYP2W1*6 and CYP2B6*6 single nucleotide polymorphisms on mitotane treatment in adrenocortical carcinoma: A multicenter ENSAT study
2020-01-01 Altieri B.; Sbiera S.; Herterich S.; De Francia S.; Casa S.D.; Calabrese A.; Pontecorvi A.; Quinkler M.; Kienitz T.; Mannelli M.; Canu L.; Angelousi A.; Chortis V.; Kroiss M.; Terzolo M.; Fassnacht M.; Ronchi C.L.
Gender-based evaluation of the effect of mitotane on total cholesterol, HDL, LDL and triglycerides levels in patients with adrenocortical carcinoma
2022-01-01 Allegra, S.; Puglisi, S.; Borin, C.; Chiara, F.; Basile, V.; Calabrese, A.; Reimondo, G.; De Francia, S.
Gender-based evaluation of the effect of mitotane on total cholesterol, HDL, LDL and triglycerides levels in patients with adrenocortical carcinoma
2022-01-01 Allegra, S.; Puglisi, S.; Borin, C.; Chiara, F.; Basile, V.; Calabrese, A.; Reimondo, G.; De Francia, S.
Mitotane concentrations influence outcome in patients with advanced adrenocortical carcinoma
2020-01-01 Puglisi S.; Calabrese A.; Basile V.; Ceccato F.; Scaroni C.; Altieri B.; Casa S.D.; Loli P.; Pivonello R.; De Martino M.C.; Canu L.; Russo M.; Badalamenti G.; Torlontano M.; Stigliano A.; Ferrau F.; Arnaldi G.; Saba L.; Quirino A.; Perotti P.; Berchialla P.; Terzolo M.
Mitotane Concentrations Influence the Risk of Recurrence in Adrenocortical Carcinoma Patients on Adjuvant Treatment
2019-01-01 Puglisi S, Calabrese A, Basile V, Ceccato F, Scaroni C, Simeoli C, Torlontano M, Cannavò S, Arnaldi G, Stigliano A, Malandrino P, Saba L, Altieri B, Della Casa S, Perotti P, Berchialla P, De Filpo G, Canu L, Loli P, Reimondo G, Terzolo M.
Mitotane: new facts for an old drug
2019-01-01 A.Calabrese,S.Puglisi,V.Basile,P.Perotti,M.Terzolo
New findings on presentation and outcome of patients with adrenocortical cancer: results from a national cohort study
2023-01-01 Soraya Puglisi; Anna Calabrese; Francesco Ferraù; Maria Antonia Violi; Marta Laganà; Salvatore Grisanti; Filippo Ceccato; Carla Scaroni; Guido Di Dalmazi; Antonio Stigliano; Barbara Altieri; Letizia Canu; Paola Loli; Rosario Pivonello; Emanuela Arvat; Valentina Morelli; Paola Perotti; Vittoria Basile; Paola Berchialla; Sara Urru; Cristian Fiori; Francesco Porpiglia; Alfredo Berruti; Anna Pia; Giuseppe Reimondo; Salvatore Cannavò; Massimo Terzolo.
New perspectives for mitotane treatment of adrenocortical carcinoma
2020-01-01 Puglisi S.; Calabrese A.; Basile V.; Pia A.; Reimondo G.; Perotti P.; Terzolo M.
Oligometastatic adrenocortical carcinoma: the role of image-guided thermal ablation
2020-01-01 Veltri A.; Basile D.; Calandri M.; Bertaggia C.; Volante M.; Porpiglia F.; Calabrese A.; Puglisi S.; Basile V.; Terzolo M.
Recovery of adrenal insufficiency is frequent after adjuvant mitotane therapy in patients with adrenocortical carcinoma
2020-01-01 Poirier J.; Gagnon N.; Terzolo M.; Puglisi S.; Ghorayeb N.E.; Calabrese A.; Lacroix A.; Bourdeau I.
S-GRAS score for prognostic classification of adrenocortical carcinoma: an international, multicenter ENSAT study
2022-01-01 Elhassan Y.S.; Altieri B.; Berhane S.; Cosentini D.; Calabrese A.; Haissaguerre M.; Kastelan D.; Fragoso M.C.B.V.; Bertherat J.; Al Ghuzlan A.; Haak H.; Boudina M.; Canu L.; Loli P.; Sherlock M.; Kimpel O.; Lagana M.; Sitch A.J.; Arlt W.; Kroiss M.; Terzolo M.; Berruti A.; Deeks J.J.; Libe R.; Fassnacht M.; Ronchi C.L.
Sex Differences on Mitotane Concentration and Treatment Outcome in Patients with Adrenocortical Carcinoma
2021-01-01 Allegra, Sarah; Puglisi, Soraya; Brescia, Irene; Chiara, Francesco; Basile, Vittoria; Calabrese, Anna; Reimondo, Giuseppe; De Francia, Silvia
SEX DIFFERENCES ON MITOTANE CONCENTRATION AND TREATMENT OUTCOME IN PATIENTS WITH ADRENOCORTICAL CARCINOMA
2021-01-01 Sarah Allegra; Soraya Puglisi; Irene Brescia; Francesco Chiara; Vittoria Basile; Anna Calabrese; Giuseppe Reimondo; Silvia De Francia
Sex-Based Evaluation of Lipid Profile in Postoperative Adjuvant Mitotane Treatment for Adrenocortical Carcinoma
2022-01-01 Sarah Allegra, Soraya Puglisi , Chiara Borin, Francesco Chiara, Vittoria Basile, Anna Calabrese, Giuseppe Reimondo, Silvia De Francia
The management of post-operative disease recurrence in patients with adrenocortical carcinoma: a retrospective study in 106 patients
2023-01-01 Anna Calabrese, Soraya Puglisi, Chiara Borin, Vittoria Basile , Paola Perotti, Anna Pia, Paola Berchialla, Marco Volante, Cristian Fiori, Francesco Porpiglia, Andrea Veltri, Giuseppe Reimondo, Massimo Terzolo
Unwanted hormonal and metabolic effects of postoperative adjuvant mitotane treatment for adrenocortical cancer
2020-01-01 Basile V.; Puglisi S.; Calabrese A.; Pia A.; Perotti P.; Berruti A.; Reimondo G.; Terzolo M.
What is the optimal duration of adjuvant mitotane therapy in adrenocortical carcinoma? An unanswered question
2021-01-01 Basile V.; Puglisi S.; Altieri B.; Canu L.; Libe R.; Ceccato F.; Beuschlein F.; Quinkler M.; Calabrese A.; Perotti P.; Berchialla P.; Dischinger U.; Megerle F.; Baudin E.; Bourdeau I.; Lacroix A.; Loli P.; Berruti A.; Kastelan D.; Haak H.R.; Fassnacht M.; Terzolo M.
Titolo | Data di pubblicazione | Autore(i) | File |
---|---|---|---|
Adjuvant mitotane therapy is beneficial in non-metastatic adrenocortical carcinoma at high risk of recurrence. | 2019 | Calabrese A, Basile V, Puglisi S, Perotti P, Pia A, Saba L, Berchialla P, Porpiglia F, Veltri A, Volante M, Reimondo G, Berruti A, Terzolo M. | |
Effects of germline CYP2W1*6 and CYP2B6*6 single nucleotide polymorphisms on mitotane treatment in adrenocortical carcinoma: A multicenter ENSAT study | 2020 | Altieri B.; Sbiera S.; Herterich S.; De Francia S.; Casa S.D.; Calabrese A.; Pontecorvi A.; Quinkler M.; Kienitz T.; Mannelli M.; Canu L.; Angelousi A.; Chortis V.; Kroiss M.; Terzolo M.; Fassnacht M.; Ronchi C.L. | |
Gender-based evaluation of the effect of mitotane on total cholesterol, HDL, LDL and triglycerides levels in patients with adrenocortical carcinoma | 2022 | Allegra, S.; Puglisi, S.; Borin, C.; Chiara, F.; Basile, V.; Calabrese, A.; Reimondo, G.; De Francia, S. | |
Gender-based evaluation of the effect of mitotane on total cholesterol, HDL, LDL and triglycerides levels in patients with adrenocortical carcinoma | 2022 | Allegra, S.; Puglisi, S.; Borin, C.; Chiara, F.; Basile, V.; Calabrese, A.; Reimondo, G.; De Francia, S. | |
Mitotane concentrations influence outcome in patients with advanced adrenocortical carcinoma | 2020 | Puglisi S.; Calabrese A.; Basile V.; Ceccato F.; Scaroni C.; Altieri B.; Casa S.D.; Loli P.; Pivonello R.; De Martino M.C.; Canu L.; Russo M.; Badalamenti G.; Torlontano M.; Stigliano A.; Ferrau F.; Arnaldi G.; Saba L.; Quirino A.; Perotti P.; Berchialla P.; Terzolo M. | |
Mitotane Concentrations Influence the Risk of Recurrence in Adrenocortical Carcinoma Patients on Adjuvant Treatment | 2019 | Puglisi S, Calabrese A, Basile V, Ceccato F, Scaroni C, Simeoli C, Torlontano M, Cannavò S, Arnaldi G, Stigliano A, Malandrino P, Saba L, Altieri B, Della Casa S, Perotti P, Berchialla P, De Filpo G, Canu L, Loli P, Reimondo G, Terzolo M. | |
Mitotane: new facts for an old drug | 2019 | A.Calabrese,S.Puglisi,V.Basile,P.Perotti,M.Terzolo | |
New findings on presentation and outcome of patients with adrenocortical cancer: results from a national cohort study | 2023 | Soraya Puglisi; Anna Calabrese; Francesco Ferraù; Maria Antonia Violi; Marta Laganà; Salvatore Grisanti; Filippo Ceccato; Carla Scaroni; Guido Di Dalmazi; Antonio Stigliano; Barbara Altieri; Letizia Canu; Paola Loli; Rosario Pivonello; Emanuela Arvat; Valentina Morelli; Paola Perotti; Vittoria Basile; Paola Berchialla; Sara Urru; Cristian Fiori; Francesco Porpiglia; Alfredo Berruti; Anna Pia; Giuseppe Reimondo; Salvatore Cannavò; Massimo Terzolo. | |
New perspectives for mitotane treatment of adrenocortical carcinoma | 2020 | Puglisi S.; Calabrese A.; Basile V.; Pia A.; Reimondo G.; Perotti P.; Terzolo M. | |
Oligometastatic adrenocortical carcinoma: the role of image-guided thermal ablation | 2020 | Veltri A.; Basile D.; Calandri M.; Bertaggia C.; Volante M.; Porpiglia F.; Calabrese A.; Puglisi S.; Basile V.; Terzolo M. | |
Recovery of adrenal insufficiency is frequent after adjuvant mitotane therapy in patients with adrenocortical carcinoma | 2020 | Poirier J.; Gagnon N.; Terzolo M.; Puglisi S.; Ghorayeb N.E.; Calabrese A.; Lacroix A.; Bourdeau I. | |
S-GRAS score for prognostic classification of adrenocortical carcinoma: an international, multicenter ENSAT study | 2022 | Elhassan Y.S.; Altieri B.; Berhane S.; Cosentini D.; Calabrese A.; Haissaguerre M.; Kastelan D.; Fragoso M.C.B.V.; Bertherat J.; Al Ghuzlan A.; Haak H.; Boudina M.; Canu L.; Loli P.; Sherlock M.; Kimpel O.; Lagana M.; Sitch A.J.; Arlt W.; Kroiss M.; Terzolo M.; Berruti A.; Deeks J.J.; Libe R.; Fassnacht M.; Ronchi C.L. | |
Sex Differences on Mitotane Concentration and Treatment Outcome in Patients with Adrenocortical Carcinoma | 2021 | Allegra, Sarah; Puglisi, Soraya; Brescia, Irene; Chiara, Francesco; Basile, Vittoria; Calabrese, Anna; Reimondo, Giuseppe; De Francia, Silvia | |
SEX DIFFERENCES ON MITOTANE CONCENTRATION AND TREATMENT OUTCOME IN PATIENTS WITH ADRENOCORTICAL CARCINOMA | 2021 | Sarah Allegra; Soraya Puglisi; Irene Brescia; Francesco Chiara; Vittoria Basile; Anna Calabrese; Giuseppe Reimondo; Silvia De Francia | |
Sex-Based Evaluation of Lipid Profile in Postoperative Adjuvant Mitotane Treatment for Adrenocortical Carcinoma | 2022 | Sarah Allegra, Soraya Puglisi , Chiara Borin, Francesco Chiara, Vittoria Basile, Anna Calabrese, Giuseppe Reimondo, Silvia De Francia | |
The management of post-operative disease recurrence in patients with adrenocortical carcinoma: a retrospective study in 106 patients | 2023 | Anna Calabrese, Soraya Puglisi, Chiara Borin, Vittoria Basile , Paola Perotti, Anna Pia, Paola Berchialla, Marco Volante, Cristian Fiori, Francesco Porpiglia, Andrea Veltri, Giuseppe Reimondo, Massimo Terzolo | |
Unwanted hormonal and metabolic effects of postoperative adjuvant mitotane treatment for adrenocortical cancer | 2020 | Basile V.; Puglisi S.; Calabrese A.; Pia A.; Perotti P.; Berruti A.; Reimondo G.; Terzolo M. | |
What is the optimal duration of adjuvant mitotane therapy in adrenocortical carcinoma? An unanswered question | 2021 | Basile V.; Puglisi S.; Altieri B.; Canu L.; Libe R.; Ceccato F.; Beuschlein F.; Quinkler M.; Calabrese A.; Perotti P.; Berchialla P.; Dischinger U.; Megerle F.; Baudin E.; Bourdeau I.; Lacroix A.; Loli P.; Berruti A.; Kastelan D.; Haak H.R.; Fassnacht M.; Terzolo M. |